Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCEND III: Asacol 4.8 g/day vs 2.4 g/day in Moderately Active Ulcerative Colitis
NCT00350415Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Jun 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by Warner Chilcott. Started Jun 2006; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00350415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350415.